Designed by London-based Radley Yeldar, the new website aims to reflect the transformation of the healthcare business to focus entirely on biopharmaceutical innovation. The GSK website aims to define a category by hosting specially created content.
In line with the brand identity of Wolff Olins GSK updateRadley Yeldar’s work will continue to underscore the company’s move away from consumer healthcare after the brand spun off in June.
Seeking to create a website that could inform and engage GSK’s diverse global audience, the Radley Yeldar team worked closely with GSK to create a website that could provide a smooth and dynamic experience. The website update is designed to evoke the ever-changing, forward-looking and increasingly digital nature of GSK.
George Butler, Chief Digital Officer at Radley Yeldar, said: “From the outset, it was clear how much GSK wanted to make a statement with a new purpose-driven site that matches its leadership in innovation, R&D and advanced science – we immediately understood the importance of the project for the future of the company.
“We are proud to have been part of creating a site that we believe leads the industry, will attract world-class talent and is suitable for a cutting-edge science and technology organization that brings together people to make life-changing discoveries. We look forward to continuing our work with GSK to deliver ever more compelling digital experiences to their stakeholders and build on their already inimitable reputation.
The website is intimately associated with Wolff Olins’ visual identity designs, creating what GSK hopes will be a seamless user experience with a ‘Netflix-style’ approach to content that represents the care company’s ‘Ahead Together’ strategy. health. Some of the website’s key features include an online magazine ‘Behind the Science’ and a video hub dedicated to ‘exceptional people’.
For more Transform content, you can subscribe to our quarterly magazine here.